Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit
This study has been withdrawn prior to enrollment.
( Study has been withdrawn as the H1N1 epidemic made this study redundant )
Study NCT00844155 Information provided by University of Manitoba
First Received on February 13, 2009. Last Updated on April 1, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza A Virus Infection
Influenza B Virus Infection
Additional conditions recognized in this trial
Encephalitis, Herpes Simplex
Influenza, Human
Virus Diseases
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
DNA Virus Infections
Encephalitis
Encephalitis, Viral
Herpesviridae Infections
Nervous System Diseases
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Interventions listed in this trial
Oseltamivir 75 mg
Additional drug interventions recognized in this trial
Oseltamivir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Manitoba
Hoffmann-La Roche
Back to top of Main Content
